The Receptor Tyrosine Kinase TrkA Is Increased and Targetable in HER2-Positive Breast Cancer

The tyrosine kinase receptor A (NTRK1/TrkA) is increasingly regarded as a therapeutic target in oncology. In breast cancer, TrkA contributes to metastasis but the clinicopathological significance remains unclear. In this study, TrkA expression was assessed via immunohistochemistry of 158 invasive du...

Descripción completa

Detalles Bibliográficos
Autores principales: Griffin, Nathan, Marsland, Mark, Roselli, Severine, Oldmeadow, Christopher, Attia, John, Walker, Marjorie M., Hondermarck, Hubert, Faulkner, Sam
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2020
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7564775/
https://www.ncbi.nlm.nih.gov/pubmed/32957504
http://dx.doi.org/10.3390/biom10091329

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7564775/
https://www.ncbi.nlm.nih.gov/pubmed/32957504
http://dx.doi.org/10.3390/biom10091329

Ejemplares similares